Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
September 18, 2011
9/20/2011 September 18, 2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices Unilife Corporation recently announced the development of its AutoInfusor portfolio...
September 11, 2011
9/13/2011 September 11, 2011
Evotec & Roche to Develop Compound That Could Slow AD Progression Evotec AG and Roche AG recently announced they have...
August 25, 2011
8/30/2011 August 25, 2011
Avantor Performance Materials Expands Portfolio Avantor Performance Materials recently announced it has expanded its portfolio by offering cGMP-manufactured Methylene Chloride...
August 18, 2011
8/23/2011 August 18, 2011
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement Intellipharmaceutics International Inc. recently announced that they have added the development...
August 18, 2011
Alexza Pharmaceuticals Announces PDUFA Goal Date August 18, 2011
Alexza Pharmaceuticals, Inc. recently announced the US FDA has accepted the ADASUVE NDA as a complete, class 2 response to...
August 11, 2011
8/16/2011 August 11, 2011
Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing...
August 4, 2011
8/9/2011 August 4, 2011
Celgene & Acceleron Enter Agreement Worth Up to $242 Million Celgene Corporation and Acceleron Pharma, Inc. recently announced they...
July 17, 2011
7/19/2011 July 17, 2011
Catalent & Sanwa Announce Exclusive License Agreement Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho Co., Ltd. have recently entered into...
July 17, 2011
Catalent & Sanwa Announce Exclusive License Agreement July 17, 2011
Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho Co., Ltd. have recently entered into an exclusive agreement to bring Sanwa's innovative...
July 6, 2011
7/12/2011 July 6, 2011
Evotec & Roche to Jointly Develop Biomarkers in Oncology Evotec AG and Roche recently announced a collaboration in novel...
June 15, 2011
6/21/2011 June 15, 2011
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity Tekmira Pharmaceuticals Corporation recently provided comments...
June 1, 2011
6/7/2011 June 1, 2011
Avantor Performance Materials Expands Presence in India Avantor Performance Materials recently announced it has opened a new pharmaceuticals formulation applications...
May 19, 2011
5/24/2011 May 19, 2011
Sartorius Stedim Biotech & RAUMEDIC Sign Partnership Agreement Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and...
May 5, 2011
5/10/2011 May 5, 2011
QRxPharma Completes Patient Enrolment of Phase III Comparative Safety Study QRxPharma Limited recently announced it has completed patient enrolment for...
April 19, 2011
4/26/2011 April 19, 2011
Precision NanoSystems & Alnylam Form New Delivery Collaboration Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company,...
April 7, 2011
4/12/2011 April 7, 2011
IBM & the Institute of Bioengineering & Nanotechnology Find Breakthrough TreatmentResearchers from IBM and the Institute of Bioengineering and Nanotechnology...
March 27, 2011
3/29/2011 March 27, 2011
Champions Biotechnology Announces Technology Collaboration With CephalonChampions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon,...
March 13, 2011
3/15/2011 March 13, 2011
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development...
February 27, 2011
3/1/2011 February 27, 2011
Elan & PPD Announce Global Business Relationship in Drug Development Elan, plc and PPD, Inc. recently announced they have formed...
February 10, 2011
2/15/2011 February 10, 2011
BASF & Medi-Solve Coatings to Develop Multifunctional Coating Solutions for Medical Devices BASF Future Business GmbH and Medi-Solve Coatings LLC...Company Profiles
December 5, 2025














